2022
DOI: 10.1016/j.celrep.2022.110762
|View full text |Cite
|
Sign up to set email alerts
|

A Cd9+Cd271+ stem/progenitor population and the SHP2 pathway contribute to neonatal-to-adult switching that regulates tendon maturation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 62 publications
1
7
0
Order By: Relevance
“…In this regard a recent study on the development of mouse tendon tissue indicated that the time interval between postnatal day 4 (P4) and P12 is the critical stage for postnatal tendon maturation [46]. Specifically, this study demonstrated that the gene expression of scleraxis, mohawk, type IA1 collagen and tenomodulin peaked at P4, followed by a substantial reduction in the relative amount of cells in the tendon tissue between P14 and P28 [46]. In a study on human fetal posterior tibial tendons samples obtained from 22-28 week old fetuses showed a higher relative amount of cells in the tendon tissue than samples obtained from 32-38 week old fetuses [28].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In this regard a recent study on the development of mouse tendon tissue indicated that the time interval between postnatal day 4 (P4) and P12 is the critical stage for postnatal tendon maturation [46]. Specifically, this study demonstrated that the gene expression of scleraxis, mohawk, type IA1 collagen and tenomodulin peaked at P4, followed by a substantial reduction in the relative amount of cells in the tendon tissue between P14 and P28 [46]. In a study on human fetal posterior tibial tendons samples obtained from 22-28 week old fetuses showed a higher relative amount of cells in the tendon tissue than samples obtained from 32-38 week old fetuses [28].…”
Section: Discussionmentioning
confidence: 99%
“…A clinical study found no improvement of anterior cruciate ligament reconstruction by injection of UA-ADRCs into a bone-tendon-bone (BTB) graft derived from the patella and related tendons compared without injection of UA-ADRCs [46]. However, the description of the infiltration procedure of the BTB graft with UA-ADRCs in that study [52] does not exclude the cells were injected mostly into the tendon part of the BTB graft, which may have limited the success of their approach.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Recent studies appear to confirm a key role for neurotropic axis molecules, such as NGF and its downstream cognates EGR1 and EGR2, in managing the transition from immature tendon cells to tenocytes ( 41 ), thus accompanying the structural evolution from neonate to early post-natal tendons ( 42 ), which recognize an increased level of complexity.…”
Section: Discussionmentioning
confidence: 99%
“…Hence, an overall understanding of tendon differentiation and molecular pathways is needed to develop strategies for restoring tendon function. Fan et al 119 identified the regulatory role of a nerve growth factor-secreting Cd9 + Cd271 + tendon stem/progenitor cluster in tendon maturation and the NGF/SHP2 pathway. Nakajima T et al 120 used scRNA-seq to analyze the developmental trajectory of induced pluripotent stem cell-derived tenocytes and found that cell grafting contributed to efficient motor function recovery after Achilles tendon damage in rats, implying that human pluripotent stem cell-derived tenocytes had therapeutic potential in the context of tendon injury.…”
Section: Introductionmentioning
confidence: 99%